|Articles|November 4, 2022

Supplements and Featured Publications

  • Microinjection via the Suprachoroidal Space: A Review of a Novel Mode of Administration
  • Volume 28
  • Issue 13

Participating Faculty: Microinjection via the Suprachoroidal Space: A Review of a Novel Mode of Administration

FACULTY

Thomas Ciulla, MD, MBA

Chief Medical Officer & Chief Development Officer Clearside Biomedical

Alpharetta, GA


Volunteer Clinical Professor

Indiana University School of Medicine Indianapolis, Indiana


Steven Yeh, MD

Professor of Ophthalmology Truhlsen Eye Institute

University of Nebraska Medical Center Omaha, NE


FACULTY DISCLOSURES

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

Thomas Ciulla, MD, MBA

STOCK OWNERSHIP

Clearside Biomedical


EMPLOYMENT

Clearside Biomedical


Steven Yeh, MD

CONSULTANCIES OR PAID ADVISORY BOARDS

Bausch + Lomb, Adverum Biotechnologies, REGENXBIO

Articles in this issue

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo